Mounjaro, PCOS and pregnancy: what the evidence says

Why this question deserves a direct answer, not a deflection

A question our prescribers hear most weeks, especially from people with PCOS, is some version of: "Can I stay on Mounjaro while I try to get pregnant, or should I come off it first?" It is a fair and important question. The honest answer is that tirzepatide should not be used if you are trying to conceive, are already pregnant or are breastfeeding. The drug's potential effects on a developing pregnancy have not been established in human studies, and until they are, the prescribing guidance is unambiguous: stop treatment before actively trying for a baby.

What makes PCOS different from many other situations is that people with the condition often have a complicated relationship between weight, hormones and fertility all at once. Weight loss can restore ovulation for some people with PCOS, which means pregnancy may become possible sooner than expected after starting treatment. That is something to plan for, not be surprised by.

The decision framework, then, is not simply "take it or leave it", it is about sequencing: what needs to happen before pregnancy, what stops when, and what monitoring looks like in between. None of that is something to work out alone. Our guidance on pregnancy and tirzepatide goes into detail on exactly how that sequencing works and what you need to consider at each stage.

What we know about PCOS, weight and fertility

PCOS is one of the most common hormonal conditions in people of reproductive age. Excess weight does not cause PCOS, but it can intensify its effects: more disrupted cycles, more androgen-driven symptoms, and a harder time conceiving. The relationship between Mounjaro and PCOS is an area of active clinical interest precisely because tirzepatide acts on two gut-hormone receptors, GIP and GLP-1, both of which influence insulin sensitivity, a central problem in PCOS.

Even modest weight reduction can shift the hormonal balance enough to restart ovulation. That is clinically significant, but it also means that contraception planning cannot be an afterthought while on treatment. The NHS notes that for people taking tirzepatide who rely on oral contraceptive pills, an additional non-oral method such as condoms should be used for the first four weeks of treatment and for four weeks after every dose increase, because gastric slowing may reduce pill absorption. This guidance applies with particular force when fertility is already in flux due to PCOS. NHS England's guidance on weight-management injections sets this out clearly for prescribers and patients alike.

If you have PCOS and your periods have been irregular, do not assume ovulation has not occurred just because your cycle is unpredictable. Your prescriber and gynaecologist should know this context.

Stopping Mounjaro before pregnancy: what the guidance says

There are no human data on tirzepatide exposure in pregnancy. Animal studies, as referenced in the prescribing documentation, showed harm at doses relevant to the human therapeutic range. The advice from the NHS tirzepatide page is clear: do not use it during pregnancy, and stop it before trying to conceive. The MHRA's guidance for GLP-1 medicines similarly advises using contraception while on treatment and through an appropriate washout period before attempting conception.

What that washout period looks like in practice is a question for your prescriber or fertility specialist, it depends on your clinical picture, any comorbidities (such as type 2 diabetes, which can co-exist with PCOS), and your reproductive timeline. There is no single answer that applies universally. What is consistent is the direction: plan the stop, do not improvise it.

If you became pregnant unexpectedly while on Mounjaro, stop taking it and contact your GP or maternity team promptly. Your prescriber at nume should also be informed. You can find more detail on Mounjaro use and pregnancy in our dedicated resource, which covers what the evidence currently shows and who to contact urgently.

Planning a PCOS-aware approach to treatment and pregnancy

For many people with PCOS, the sequence that makes clinical sense is: weight management first, conception planning second, with a clear stop point built in. That is not a reason to defer seeking help, it is a reason to get proper clinical support early, so the plan is already in place when it matters.

If you have already had a pregnancy or are in the postpartum period and are considering returning to treatment, our page on Mounjaro after pregnancy covers the specific considerations for that stage. If you are earlier in the process and still mapping out what treatment options exist for your situation, our free consultation is the starting point, a GPhC-registered prescriber reviews every application personally and will factor in your PCOS, your reproductive plans, and any other relevant history before making a clinical decision. Nothing is approved automatically.

PCOS does not disqualify you from treatment. Pregnancy plans, or the possibility of becoming pregnant, change the clinical picture significantly. Those two facts sit together, and the right specialist (whether that is your GP, a gynaecologist or an obesity medicine prescriber) can help you hold both at once. Our clinical team is available to answer questions through our aftercare service seven days a week.